FindTrial
Sign In

Canceled by the investigator. Combination of intranasal dexmedetomidine and oral midazolam for deep sedation in children

Application of intranasal dexmedetomidine combined with oral midazolam for deep sedation in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080107
Enrollment
Unknown
Registered
2024-01-19
Start date
2024-01-23
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

chloral hydrate group:Oral chloral hydrate 50mg/kg
midazolam plus intranasal dexmedetomidine group:0.2mg/kg oral chloral hydrate plus 2ug/kg intranasal dexmedetomidine
Dexmedetomidine plus sevoflurane group:Intranasal dexmedetomidine 1.0 ug/kg plus sevoflurane

Sponsors

Yuxi Children`s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 15 Years

Inclusion criteria

Inclusion criteria: 1 ASA Level 1-3 2 Ages 0-15 years old 3 Children with cardiac ultrasonography, CT and other examinations under pseudo-sedation

Exclusion criteria

Exclusion criteria: 1 Family members declined to participate in the study 2 Children with cyanotic congenital heart disease 3 Children with abnormal neurological or psychiatric development 4 weeks of gestation + preterm infants aged less than 42 weeks after birth 5 Children whose condition requires fasting 6 Children with known hepatic and renal impairment

Design outcomes

Primary

MeasureTime frame
the rate of successful sedation;—

Secondary

MeasureTime frame
duration of sedation;recovery time;—

Countries

China

Contacts

Public ContactGuo Hongsong

Yuxi Children`s Hospital

309626473@qq.com+86 150 8770 8399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026